(Adnkronos) "We have to build a shared governance, drug and health in general. Clearly the Aifa-Aiom table of this summer on oncology and oncoematology is very important because we want an Aifa dialogue with scientific societies, with institutions, but also with patient associations. It is clear that regulatory decisions must respond [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
(Adnkronos) "We have to build a shared governance, drug and health in general. Clearly the Aifa-Aiom table of this summer on oncology and oncoematology is very important because we want an Aifa dialogue with scientific societies, with institutions, but also with patient associations. It is clear that regulatory decisions must respond [...]
(Adnkronos) "We have to build a shared governance, drug and health in general. Clearly the Aifa-Aiom table of this summer on oncology and oncoematology is very important because we want an Aifa dialogue with scientific societies, with institutions, but also with patient associations. It is clear that regulatory decisions must respond [...]